en.wikipedia.org website review
Improve your SEO :: free trial!
en.wikipedia.org is 52% geoptimaliseerd!
SEO Keyword summary for en.wikipedia.org/wiki/eculizumab
Keywords are extracted from the main content of your website and are the primary indicator of the words this page could rank for. By frequenty count we expect your focus keyword to be from
Focus keyword
Short and long tail
Short Tail Keywords from eculizumab original |
long Tail Keywords (2 words) february 2023 27 february 2023 retrieved paroxysmal nocturnal b c |
long Tail Keywords (3 words) 27 february 2023 paroxysmal nocturnal hemoglobinuria february 2023 retrieved retrieved 27 february european medicines agency 25 june 2015 original on 27 |
en.wikipedia.org On-Page SEO Scan
Descriptive Elements
The <head> element of a en.wikipedia.org/wiki/eculizumab page is used to inform the browser and visitors of the page about the general meta information. The head section of the page is where we place the page title, the definition of the HTML version used, the language of in which the page is written. In the head section we can also include JavaScript and CSS (markup) files for the page.
Page title
Title length
eculizumab wikipedia
Meta description
Meta description legth
Meta description SEO
No meta relevance in the description detected !
Content SEO
Number of Words
Spam detected?
Headings
Heading distribution
Heading normalisation
Heading SEO impact
Emphasis (bold and italic)
Emphasis SEO impact
Images
Number of images
Images dimensions
Image alt descriptions
Images SEO impact
wikipedia free encyclopedia check public domain icon wikimedia foundation powered mediawiki
Mobile SEO en.wikipedia.org/wiki/eculizumab
Mobile rendering
Mobile optimizations
Responsive design detected (mobile css)
No flash detected !
Mobile improvement
Marketing / lead generation for en.wikipedia.org/wiki/eculizumab
Social Media
Facebook shares | Facebook likes | ||
Facebook comments | Tweets | ||
Google +1 |
Conversion form
Search form
Analytics
Online presence
SERP Preview
SERP Title
SERP Link
SERP Description
Domain Level SEO
Domain name
16 characters long
Domain name SEO Impact
Path name
eculizumab found in path !
Structured data
Publisher Markup
Other Structured data
Website configuration
Correct processing of non-existing pages?
Favicon icon found?
Robots.txt found?
Sitemap found?
Navigation and internal links
Navigation
Url seperator
Human readable urls
Number of links
Link SEO Impact
statistics
|
en.m.wikipedia.org |
en.wikipedia.org wikimedia foundation inc
|
w view history
httpsenwikipediaorgwindexphptitleeculizumaboldid1236120267
page information
printable version
|
wiki read
ocrelizumab
monoclonal
humanized
mouse
target
complement system
trade names
biosimilar
drugscom
medlineplus
legal status
dailymed
pregnancycategory
routes ofadministration
intravenous
drug class
l04
boxed warning
pharmacokinetic
elimination halflife
cas number
drugbank
chemspider
kegg
chembl
molar mass
humanized monoclonal antibody
paroxysmal nocturnal hemoglobinuria
atypical hemolytic uremic syndrome
myasthenia gravis
neuromyelitis optica
destruction of red blood cells
blood transfusion
intravenous infusion
developed
alexion pharmaceuticals
indicated
myelodysplastic syndrome
acute myelogenous leukemia
aplastic anemia
meningococcal infections
meningococcal
meningococcal disease
loss of red blood cells
red blood cells
blood clots forming in small blood vessels
loss of white blood cells
anaphylactic reaction
hypersensitivity reaction
heart palpitations
peritonitis
blotches from small bleeds under the skin
skin redness
hives
edema
elevated transaminases
c5 convertase
lysosomal
enzymes
antibodies
volume of distribution
plasma
immunoglobulin
molecular weight
food and drug administration
orphan drug
european medicines agency
antiaquaporin4 aqp4 antibody positive
public relations
ontario canada
health canada
patented medicine prices review board
canadian patent act
opportunity cost
universal health care system
reais
sofosbuvir
committee for medicinal products for human use
chaple syndrome
fda
pmid
s2cid
public domain
isbn
the new york times
wayback machine
de standaard
de morgen
immunosuppressive drugs
immunosuppression
antimetabolites
purine synthesis inhibitors
azathioprine
mycophenolic acid
dihydroorotate dehydrogenase
leflunomide
teriflunomide
antifolate
methotrexate
macrolides
il2
fkbp
cyclophilin
calcineurin
ciclosporin
pimecrolimus
tacrolimus
voclosporin
abetimus
gusperimus
lenalidomide
pomalidomide
thalidomide
pde4 inhibitor
apremilast
il1 receptor antagonists
anakinra
mtor
everolimus
ridaforolimus
sirolimus
temsirolimus
umirolimus
zotarolimus
tnf inhibitor
adalimumab
afelimomab
certolizumab pegol
golimumab
infliximab
nerelimomab
interleukin
basiliximab
bimekizumab
briakinumab
brodalumab
canakinumab
daclizumab
guselkumab
ixekizumab
olokizumab
rilonacept
risankizumab
sarilumab
satralizumab
secukinumab
siltuximab
sirukumab
spesolimab
tildrakizumab
tocilizumab
ustekinumab
interleukin 5
mepolizumab
immunoglobulin e
omalizumab
interferon
faralimomab
il6
elsilimomab
il12
il13
il23
lebrikizumab
il17a
muromonabcd3
otelixizumab
teplizumab
visilizumab
cd4
clenoliximab
keliximab
zanolimumab
cd11a
efalizumab
cd18
erlizumab
cd20
obinutuzumab
hyaluronidase
pascolizumab
rituximab
ublituximab
cd23
gomiliximab
lumiliximab
cd40
teneliximab
toralizumab
cd62llselectin
aselizumab
cd80
galiximab
cd147basigin
gavilimomab
cd154
frexalimab
ruplizumab
belimumab
bertilimumab
lerdelimumab
metelimumab
integrin
natalizumab
vedolizumab
interleukin6 receptor
odulimomab
il2 receptorcd25
inolimomab
tlymphocyte
zolimomab aritox
alemtuzumab
anifrolumab
atorolimumab
cedelizumab
emapalumab
fontolizumab
inebilizumab
maslimomab
morolimumab
ofatumumab
pexelizumab
reslizumab
rovelizumab
siplizumab
talizumab
telimomab aritox
teprotumumab
vapaliximab
vepalimomab
polyclonal
antithymocyte globulin
antilymphocyte globulin
fusion
ctla4
abatacept
belatacept
etanercept
aflibercept
alefacept
avacopan
baricitinib
blisibimod
crovalimab
danicopan
darvadstrocel
deucravacitinib
deuruxolitinib
dimethyl fumarate
diroximel fumarate
efgartigimod alfa
hyaluronidase
etrasimod
filgotinib
fingolimod
iptacopan
ozanimod
peficitinib
pegcetacoplan
pirfenidone
ponesimod
ravulizumab
ritlecitinib
rozanolixizumab
siponimod
sutimlimab
tofacitinib
upadacitinib
monoclonal antibodies
immune system
abrilumab
avelumab
bleselumab
camidanlumab tesirine
carlumab
cemiplimab
dupilumab
eldelumab
fresolimumab
ianalumab
lanadelumab
lenzilumab
lirentelimab
lirilumab
mavrilimumab
namilumab
oleclumab
oxelumab
pamrevlumab
placulumab
relatlimab
sifalimumab
tabalumab
tezepelumab
ulocuplumab
varlilumab
ipilimumab
durvalumab
nivolumab
tremelimumab
urelumab
nivolumabrelatlimab
chimeric
andecaliximab
priliximab
humanized
apolizumab
atezolizumab
benralizumab
camrelizumab
crizanlizumab
epratuzumab
etrolizumab
itolizumab
lampalizumab
letolizumab
ligelizumab
lulizumab pegol
mogamulizumab
ozoralizumab
pateclizumab
pembrolizumab
pidilizumab
plozalizumab
pro 140
quilizumab
retifanlimab
rontalizumab
samalizumab
spartalizumab
teclistamab
tislelizumab
tregalizumab
vatelizumab
vobarilizumab
tgn1412
dostarlimab
ibalizumab
bermekimab
brazikumab
fezakinumab
fletikumab
tralokinumab
anrukinzumab
clazakizumab
gevokizumab
mirikizumab
perakizumab
lokivetmab
lesions
besilesomab
fanolesomab
lemalesomab
sulesomab
withdrawn
clinical trials
phase iii
c1
c4a
c4b
masp1
masp2
factor b
factor d
factor pproperdin
c3b
ic3b
c3convertase
c5convertase
c8
c1inhibitor
decayaccelerating factor
cd59
factor i
c4bp
factor h
complement receptors
cd11b
cd11c
anaphylatoxin
c3a
c5a
cytotoxicity
immune adherence
inflammation
opsonization
astrazeneca
acalabrutinib
anastrozole
andexanet alfa
asfotase alfa
atenolol
bicalutamide
brompheniramine
budesonide
budesonideformoterol
budesonideglycopyrronium bromideformoterol
candesartan
dapagliflozin
disufenton sodium
esomeprazole
exenatide
fulvestrant
gefitinib
glycopyrronium bromideformoterol
goserelin
isosorbide mononitrate
metoprolol
motavizumab
olaparib
omeprazole
osimertinib
palivizumab
propofol
quetiapine
roflumilast
rosuvastatin
roxadustat
salbutamolbudesonide
savolitinib
saxagliptin
sebelipase alfa
selumetinib
sodium zirconium cyclosilicate
tamoxifen
ticagrelor
tixagevimabcilgavimab
trastuzumab deruxtecan
vandetanib
ximelagatran
zafirlukast
zolmitriptan
astra ab
cambridge antibody technology
medimmune
zeneca
tom mckillop
louis schweitzer
|
Links to external pages
Outloing links
ca.wikipedia.org
de.wikipedia.org
es.wikipedia.org
fa.wikipedia.org
fr.wikipedia.org
it.wikipedia.org
ja.wikipedia.org
pl.wikipedia.org
pt.wikipedia.org
ru.wikipedia.org
sr.wikipedia.org
sh.wikipedia.org
uk.wikipedia.org
www.wikidata.org
www.wikidata.org
commons.wikimedia.org
www.drugs.com
www.medlineplus.gov
dailymed.nlm.nih.gov
www.whocc.no
commonchemistry.cas.org
www.drugbank.ca
precision.fda.gov
www.kegg.jp
www.ebi.ac.uk
www.ema.europa.eu
web.archive.org
web.archive.org
www.accessdata.fda.gov
web.archive.org
web.archive.org
www.medicines.org.uk
web.archive.org
dailymed.nlm.nih.gov
web.archive.org
web.archive.org
pubmed.ncbi.nlm.nih.gov
www.fda.gov
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.fda.gov
web.archive.org
www.cdc.gov
pubmed.ncbi.nlm.nih.gov
web.archive.org
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
web.archive.org
www.nytimes.com
web.archive.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.forbes.com
www.thestar.com
www.vrt.be
web.archive.org
www.vrt.be
web.archive.org
www.demorgen.be
web.archive.org
pmprb-cepmb.gc.ca
www.in.gov.br
web.archive.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
commons.wikimedia.org
foundation.wikimedia.org
foundation.wikimedia.org
foundation.wikimedia.org
www.wikimediafoundation.org
SEO Advice for en.wikipedia.org
In this section we provide pointers on how you can to optimize your web page so it can be found more easily by search engines and how to make it rank higher by optimizing the content of the page itself. For each of the individual criteria the maximum score is 100%. A score below 70% is considered to be indication that the page is not complying with general SEO standards and should be evaluated and/or fixed. Not every factor is weighted the same and some are not as important as others. Relatively unimportant factors like meta keywords are not included in the overall score.
Item | Factor | Pointers | |
---|---|---|---|
PageTitle | 100% | Far too many sites lack a page title. A page title is the first thing that shows in the search results so always use the title element. | |
Title relevance | 65% | A title should reflect the contents of a site. This site has a 50 % match | |
Title Length | 30% | Limit your title to anywhere between 40 and 70 characters. Your title was 23 characters long | |
Meta Description | 0% | A meta description is the second element that shows in the search results so always use the meta description. | |
Meta description length | 0% | The meta description should be between 145 and 160 characters. This meta description is 1 characters long. | |
Meta description relevance | 0% | Meta Description should reflect the contents of a site. This site has a 0 % match | |
Number of internal links | 30% | Linking to internal pages makes pages easier to find for search engines. Try to keep the number of links on your page roughly below 100. There are 672 internal links on this page. | |
Folder structure | 100% | We found a folder structure in the links on your page. A good folder structure makes a site easier to navigate. We found 3 level 1 folders and 14 folders above or in the first level of navigation. | |
Headings | 14% | Headers should reflect the contents of a site. This site has a 6 % match | |
Links | 6% | Link anchors should to some degree reflect the contents of a site. This site has a 3 % match | |
Image alt tags | 0% | Image alt tags should to some degree reflect the contents of a site. This site has a 0 % match | |
Bold and italic | 18% | Bold and italic tags should reflect the contents of a site to some degree. This site has a 6 % match | |
Html ratio | 40% | Try to keep the html / text ratio as low as possible. More html means longer loading times. Layout should be handled in a serpate css file | |
Image descriptions | 73% | 73.333333333333 % of all images have been described via the "alt" attribute. Describing images with relevant text may lead to better results in the search engines. | |
Page errors | 100% | Pages with no errors display significantly faster on most browsers. We detected 0 errors and warnings | |
WordCount | 20% | An ideal page contains between 400 and 600 words.This page contains 4476 words | |
Server response time | 100% | A fast server speeds up a website. This server responds 93.71% faster then average | |
Gzip compression | 30% | This site does not use Gzip compression. Pages may not display as fast as they could | |
Keywords in Domainname | 30% | There are no important keywords in your domain name | |
Keywords in domain path | 100% | There are important keywords in the domain path | |
Structured Data | 100% | Structured data makes it easier for search engines to index your website | |
Inline css | 0% | Do not use inline css declarations. Inline css will slow down the rendering of the website. We detected 181 inline style declarations ( <a style="color:green">) with a size of 3257 bytes | |
Excessive use of the same words | 100% | There is no indication that there are one or more keywords that are used excessively. | |
Frames or iframes | 100% | Perfect, detected not (i)frames on your webpagina | |
Flash | 100% | Perfect, we detected no flash objects on your page | |
Css | 30% | We detected too much (2) CSS files on your page. Css files block the loading of a webpage. | |
Javascript | 100% | Perfect, we did not detect too many blocking JavaScript files | |
Mobile Website | 100% | Perfect, we found a responsive design for mobile users | |
Most important heading | 100% | Perfect, we detected a correct use of the most important (h1) heading! | |
Normalized headings | 40% | We dit not font a normalized heading structure. A heading 2 (h2) for example should be followed by a heading of an equal level (h2), a child heading (h3) or even a aprent heading (h1). |
How would you like to have SEO advice for all your pages ?? Start your SEO Dashboard and optimize your website!
en.wikipedia.org images and descriptions
12 images found at en.wikipedia.org Images can improve the user experience for a website by making a pag visually appealing Images can also add extra keyword relevance to a webpage by using alt tags. Images can also slow down a website. If the width and height for a picture is not specified for a browser know in advance how large the image is. A browser must first load the picture and see before it knows how much space should be on the page. Upon reservation In the meantime, the browser can do little but wait. When the height and width for the plate are given in the HTML code, a browser just continues to build for a page while the images load in the background.
http://en.wikipedia.org/static/images/icons/wikipedia.png height: 50 width: 50 description: no alt description found |
|
http://en.wikipedia.org/static/images/mobile/copyright/wikipedia-wordmark-en.svg height: height attribute not set width: width attribute not set description: wikipedia |
|
http://en.wikipedia.org/static/images/mobile/copyright/wikipedia-tagline-en.svg height: 13 width: 117 description: the free encyclopedia |
|
https://upload.wikimedia.org/wikipedia/en/thumb/f/fb/yes_check.svg/7px-yes_check.svg.png height: 7 width: 7 description: check |
|
https://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/x_mark.svg/7px-x_mark.svg.png height: 8 width: 7 description: ☒ |
|
https://upload.wikimedia.org/wikipedia/en/thumb/6/62/pd-icon.svg/12px-pd-icon.svg.png height: 12 width: 12 description: public domain |
|
https://upload.wikimedia.org/wikipedia/en/thumb/9/96/symbol_category_class.svg/16px-symbol_category_class.svg.png height: 16 width: 16 description: no alt description found |
|
https://upload.wikimedia.org/wikipedia/en/thumb/4/4a/commons-logo.svg/12px-commons-logo.svg.png height: 16 width: 12 description: no alt description found |
|
https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/who_rod.svg/8px-who_rod.svg.png height: 19 width: 8 description: icon |
|
https://login.wikimedia.org/wiki/special:centralautologin/start?type=1x1 height: 1 width: 1 description: no alt description found |
|
http://en.wikipedia.org/static/images/footer/wikimedia-button.svg height: 29 width: 84 description: wikimedia foundation |
|
http://en.wikipedia.org/w/resources/assets/poweredby_mediawiki.svg height: 31 width: 88 description: powered by mediawiki |
How are images contributing to your SEO site-wise ? Your leading content tool has the awnsers!